|
⚲
|
| Keyboard |
| Freedman Edward D
✚
|
|
|---|---|
| CIK # | 0001817434 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001817434] | |
| 4 | [0001817434] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pandion Therapeutics Inc | |
| Freedman Edward D |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pandion Therapeutics Inc PAND
Common Stock
|
2021-04-01 | Tender | 54,460 | $60.00 | 3,267,600 |
|
Pandion Therapeutics Inc PAND
Employee Stock Option (Right to Buy) · derivative
|
2021-04-01 | Disposed to issuer | 55,903 | ||
|
Pandion Therapeutics Inc PAND
Employee Stock Option (Right to Buy) · derivative
|
2021-04-01 | Disposed to issuer | 36,895 | ||
|
Pandion Therapeutics Inc PAND
Stock Option (right to buy) · derivative
|
2021-02-08 | Grant | 36,895 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Common Stock
|
2020-07-21 | Conversion | 2,348 | ||
|
Pandion Therapeutics Inc PAND
Series B Preferred Stock · derivative
|
2020-07-21 | Conversion | 11,974 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Stock Option (right to buy) · derivative
|
2020-07-17 | Grant | 2,112 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Stock Option (right to buy) · derivative
|
2020-07-17 | Grant | 53,131 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Stock Option (right to buy) · derivative
|
2020-07-17 | Grant | 660 | $0.00 |